Canadian Tumour Repository Network (CTRNet): update on 3CTN collaboration to develop standardized clinical trial biospecimen collection processes
The 3CTN is a pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada in order to ensure that Canadians with cancer and those at risk will have the best available cancer treatments. 3CTN and The Canadian Tumour Repository Network (CTRNet) are working together to help ensure there is access to adequate numbers of high-quality biospecimens across their network.
As part of the establishment phase, 3CTN wants to provide education on research biospecimen handling for at least one 3CTN team member per site to ensure there is access to adequate numbers of high-quality biospecimens through standardization of clinical trial biospecimen collection processes. 3CTN is collaborating with the UBC Office of Biobank Education and Research (OBER) to assist research sites in assessing their clinical trial biospecimen collection practices. This affects any site that collects samples in the context of clinical trials, and not just those sites with a formal biobank.
More information regarding the education initiative will be circulated to the C17 sites.
To learn more about CTRNet, visit www.ctrnet.ca.